» Articles » PMID: 26981077

Tracking of Iron-labeled Human Neural Stem Cells by Magnetic Resonance Imaging in Cell Replacement Therapy for Parkinson's Disease

Overview
Date 2016 Mar 17
PMID 26981077
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Human neural stem cells (hNSCs) derived from the ventral mesencephalon are powerful research tools and candidates for cell therapies in Parkinson's disease. However, their clinical translation has not been fully realized due, in part, to the limited ability to track stem cell regional localization and survival over long periods of time after in vivo transplantation. Magnetic resonance imaging provides an excellent non-invasive method to study the fate of transplanted cells in vivo. For magnetic resonance imaging cell tracking, cells need to be labeled with a contrast agent, such as magnetic nanoparticles, at a concentration high enough to be easily detected by magnetic resonance imaging. Grafting of human neural stem cells labeled with magnetic nanoparticles allows cell tracking by magnetic resonance imaging without impairment of cell survival, proliferation, self-renewal, and multipotency. However, the results reviewed here suggest that in long term grafting, activated microglia and macrophages could contribute to magnetic resonance imaging signal by engulfing dead labeled cells or iron nanoparticles dispersed freely in the brain parenchyma over time.

Citing Articles

Human iPSC-derived neural stem cells displaying radial glia signature exhibit long-term safety in mice.

Luciani M, Garsia C, Beretta S, Cifola I, Peano C, Merelli I Nat Commun. 2024; 15(1):9433.

PMID: 39487141 PMC: 11530573. DOI: 10.1038/s41467-024-53613-7.


Current Status of Stem Cell-Derived Therapies for Parkinson's Disease: From Cell Assessment and Imaging Modalities to Clinical Trials.

Jang S, Qiu L, Chan L, Tan E, Zeng L Front Neurosci. 2020; 14:558532.

PMID: 33177975 PMC: 7596695. DOI: 10.3389/fnins.2020.558532.


In vivo Cell Tracking Using Non-invasive Imaging of Iron Oxide-Based Particles with Particular Relevance for Stem Cell-Based Treatments of Neurological and Cardiac Disease.

Glover J, Aswendt M, Boulland J, Lojk J, Stamenkovic S, Andjus P Mol Imaging Biol. 2019; 22(6):1469-1488.

PMID: 31802361 DOI: 10.1007/s11307-019-01440-4.


Comparative strategies for stem cell biodistribution in a preclinical study.

Wang F, Wang Z, Wang F, Dong K, Zhang J, Sun Y Acta Pharmacol Sin. 2019; 41(4):572-580.

PMID: 31705124 PMC: 7470780. DOI: 10.1038/s41401-019-0313-x.


Tracking Neural Progenitor Cell Migration in the Rodent Brain Using Magnetic Resonance Imaging.

Mallett C, Shuboni-Mulligan D, Shapiro E Front Neurosci. 2019; 12:995.

PMID: 30686969 PMC: 6337062. DOI: 10.3389/fnins.2018.00995.


References
1.
Sykova E, Jendelova P . Magnetic resonance tracking of implanted adult and embryonic stem cells in injured brain and spinal cord. Ann N Y Acad Sci. 2005; 1049:146-60. DOI: 10.1196/annals.1334.014. View

2.
Courtois E, Castillo C, Seiz E, Ramos M, Bueno C, Liste I . In vitro and in vivo enhanced generation of human A9 dopamine neurons from neural stem cells by Bcl-XL. J Biol Chem. 2010; 285(13):9881-9897. PMC: 2843236. DOI: 10.1074/jbc.M109.054312. View

3.
Kostura L, Kraitchman D, Mackay A, Pittenger M, Bulte J . Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed. 2004; 17(7):513-7. DOI: 10.1002/nbm.925. View

4.
Ruan J, Shen J, Wang Z, Ji J, Song H, Wang K . Efficient preparation and labeling of human induced pluripotent stem cells by nanotechnology. Int J Nanomedicine. 2011; 6:425-35. PMC: 3075908. DOI: 10.2147/IJN.S16498. View

5.
Kallur T, Farr T, Bohm-Sturm P, Kokaia Z, Hoehn M . Spatio-temporal dynamics, differentiation and viability of human neural stem cells after implantation into neonatal rat brain. Eur J Neurosci. 2011; 34(3):382-93. DOI: 10.1111/j.1460-9568.2011.07759.x. View